J. MARTIN CARROLL - 02 Jun 2022 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Director
Signature
/s/ Benjamin Looker
Issuer symbol
ESPR
Transactions as of
02 Jun 2022
Net transactions value
+$28,180
Form type
4
Filing time
03 Jun 2022, 16:11:40 UTC
Previous filing
01 Jun 2022
Next filing
21 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Purchase $28,180 +5,000 $5.64 5,000 02 Jun 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Mr. Carroll purchased these shares in a series of open market transactions.